In the News

November 12th, 2020

Shear Insights: HemoShear Therapeutics Launches Pilot Study to Evaluate Neuropsychological Assessments for MMA and PA

Read More »
September 29th, 2020

Shear Insights: Mavis Waller Appointed to Vice President, Clinical Operations as HemoShear Readies for Clinical Trials

Read More »
August 25th, 2020

HemoShear Therapeutics featured as NIH Small Business Innovation Research Grant Success Story

Read more at SBIR/STTR
August 10th, 2020

HemoShear to Present at Upcoming Investor Conferences

Read More »
June 4th, 2020

Shear Insights: Journal Publishes HemoShear Models for Rare Metabolic Diseases

Read More »
November 14th, 2019

Shear Insights: HemoShear Therapeutics Engages with European Metabolic Disease Consortium

Read More »
September 20th, 2019

Prestigious Journal Publishes HemoShear Research on Gene Expression and Liver Disease

Read More »
August 23rd, 2019

Takeda And HemoShear Therapeutics: The NASH Collaboration

Read more at Seeking Alpha
April 17th, 2019

Q&A on HemoShear’s 3D model of the tumor microenvironment

Read more at DDN News
November 9th, 2018

Shear Insights: HemoShear Identifies Novel Targets for Treating Liver Diseases

Read More »
September 6th, 2018

Shear Insights: HemoShear Invited to Share Expertise at 3D Modeling Conference

Read More »
July 19th, 2018

Shear Insights: HemoShear Therapeutics Continues to Engage with Rare Disease Groups

Read More »
View More +

Contact

info@hemoshear.com

501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902